A Bright Outlook for IJS
In the realm of Exchange-Traded Funds (ETFs), the iShares S&P Small-Cap 600 Value ETF (Symbol: IJS) has recently garnered attention. Delving into its underlying holdings, analysts have offered a glimpse into the future by comparing the trading prices against the average analyst 12-month forward target price. This has led to the revelation of a weighted average implied analyst target price for the ETF at $113.12 per unit.
The current trading price of IJS stands close to $99.01 per unit, indicating an uplifting 14.25% potential upside as envisioned by analysts looking through to the average analyst targets of the underlying holdings. Of particular interest are three prominent underlying holdings within IJS that exhibit notable potential to surpass their respective analyst target prices. These include ICU Medical Inc (Symbol: ICUI), Hudson Pacific Properties Inc (Symbol: HPP), and Berkshire Hills Bancorp Inc (Symbol: BHLB).
While ICUI has seen recent trading at $101.00 per share, analysts project a compelling 35.15% upside if the average analyst target of $136.50 per share is achieved. Similarly, HPP basks in a 32.57% upside from its recent share price of $6.22 should it reach the average analyst target price of $8.25 per share. Moreover, BHLB is anticipated to hit a target price of $27.20 per share, reflecting a robust 23.58% increase over the recent price of $22.01 per share.
For a visual insight, a twelve-month price history chart is provided below, comparing the stock performance of ICUI, HPP, and BHLB:
Key Analyst Target Prices
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares S&P Small-Cap 600 Value ETF | IJS | $99.01 | $113.12 | 14.25% |
| ICU Medical Inc | ICUI | $101.00 | $136.50 | 35.15% |
| Hudson Pacific Properties Inc | HPP | $6.22 | $8.25 | 32.57% |
| Berkshire Hills Bancorp Inc | BHLB | $22.01 | $27.20 | 23.58% |
Are these analyst targets justified or steeped in optimism about future trajectories of these stocks in the market a year from now? The validity of these projections hinges on comprehensive analysis of recent company and industry developments. While a lofty price target relative to a stock’s trading price may exude optimism, it could also signal future target price reductions if these projections are mere vestiges of the past. In essence, rigorous investor research is a requisite in discerning these trajectories.
Explore 10 ETFs With Most Upside To Analyst Targets »
Also see:
REITs Hedge Funds Are Buying
IDI Videos
Top Ten Hedge Funds Holding ASBI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
